ROTH MKM resumed coverage on Journey Medical with a new price target
$DERM
Biotechnology: Pharmaceutical Preparations
Health Care
ROTH MKM resumed coverage of Journey Medical with a rating of Buy and set a new price target of $11.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/22/2024 | $9.00 | Buy | Rodman & Renshaw |
| 6/28/2024 | $11.00 | Buy | ROTH MKM |
| 2/25/2022 | $9.00 | Overweight | Cantor Fitzgerald |
| 12/16/2021 | $15.00 | Buy | Roth Capital |
| 12/7/2021 | $14.00 | Buy | B. Riley Securities |